Vivos Inc.

RDGL ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-6.4M $-9.9M $6.2M $-18.1M $-3.5M $-8.6M $-2.7M $-4.1M
Depreciation & Amortization $1.5K $2.9K $5.7K $12.0K $208.6K $483.2K $546.4K $545.2K
Depreciation $1.5K $2.9K $4.3K $6.2K $199.7K $472.0K $539.7K $539.5K
Amortization $0 $0 $1.3K $5.8K $8.9K $11.2K $6.7K $5.7K
Stock-Based Compensation $103.9K $675.3K $80.6K $232.7K — — — —
Net Cash from Operating Activities $-1.3M $-1.9M $-1.2M $-1.1M $-2.0M $-1.8M $-858.8K $-2.4M
Investing Activities
Capital Expenditures — — — — $0 $14.8K $0 —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $2.8K — — $0 $-7.7K $-92.2K $-97.4K $-24.4K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $1.3M $1.8M $1.4M $1.1M $2.0M $1.8M $419.4K $1.2M
Net Change in Cash $-19.6K $-151.1K $178.8K $203 $-6.4K $-46.1K $-536.8K $551.8K
Free Cash Flow — — — — $-2.0M $-1.8M $-858.8K —
← Newer Page 2 of 2 Older →